🔴 Moleculin Biotech is trading 11.13% down today with no material new catalyst reported

Moleculin Biotech is trading 11.13% down at $0.74, with no material new catalyst reported.

• The decline reverses the September 10, 2026 close of $0.83 and its prior 8.48% gain.
• The H.C. Wainwright conference presentation became available on-demand at 7:00 a.m. ET; no material new catalyst was reported.
• Major U.S. indices were higher, making the decline appear company-specific or trading-driven rather than broad-market weakness.